Drug therapy for ventricular tachyarrhythmias: how many electropharmacologic trials are appropriate? (Q39234637)

10 September 2017

title

Drug therapy for ventricular tachyarrhythmias: how many electropharmacologic trials are appropriate? (English)

1 reference

10 September 2017

K M Kavanagh

1

1 reference

10 September 2017

D G Wyse

2

1 reference

10 September 2017

H J Duff

3

1 reference

10 September 2017

A M Gillis

4

1 reference

10 September 2017

R S Sheldon

5

1 reference

10 September 2017

L B Mitchell

6

1 reference

10 September 2017

language of work or name

English

0 references

publication date

1 February 1991

1 reference

Journal of the American College of Cardiology

10 September 2017

published in

1 reference

10 September 2017

volume

17

1 reference

10 September 2017

issue

2

1 reference

10 September 2017

page(s)

391-396

1 reference

PAROXYSMAL VENTRICULAR TACHYCARDIA

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980104-4

7 January 2021

Prehospital ventricular defibrillation. Prognosis and follow-up course

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980104-4

7 January 2021

A randomized clinical trial of the noninvasive and invasive approaches to drug therapy of ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980104-4

7 January 2021

Electrical stimulation of the heart in patients with ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980104-4

7 January 2021

Cardiac pacing and pacemakers II. Serial electrophysiologic-pharmacologic testing for control of recurrent tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980104-4

7 January 2021

Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980104-4

7 January 2021

Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980104-4

7 January 2021

Electrophysiologic approach to therapy of recurrent sustained ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980104-4

7 January 2021

Chronic longterm electrophysiologic study of paroxysmal ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980104-4

7 January 2021

Out-of-hospital cardiac arrest: electrophysiologic observations and selection of long-term antiarrhythmic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980104-4

7 January 2021

Accuracy of the ventricular tachycardia-induction study for predicting long-term efficacy and inefficacy of antiarrhythmic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980104-4

7 January 2021

Role of programmed stimulation in assessing vulnerability to ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980104-4

7 January 2021

Electrophysiologic testing in the management of survivors of out-of-hospital cardiac arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980104-4

7 January 2021

Determinants of survival in patients with ventricular tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980104-4

7 January 2021

Survivors of cardiac arrest: prevention of recurrence by drug therapy as predicted by electrophysiologic testing or electrocardiographic monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980104-4

7 January 2021

Antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with coronary artery disease as assessed by electrophysiologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980104-4

7 January 2021

Clinical characteristics and long-term follow-up in 119 survivors of cardiac arrest: relation to inducibility at electrophysiologic testing

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980104-4

7 January 2021

Clinical factors predicting successful electrophysiologic-pharmacologic study in patients with ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980104-4

7 January 2021

The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980104-4

7 January 2021

Procainamide, disopyramide and quinidine: discordant antiarrhythmic effects during crossover comparison in patients with inducible ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980104-4

7 January 2021

Prediction of successful suppression of sustained ventricular tachyarrhythmias by serial drug testing from data derived at the initial electrophysiologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980104-4

7 January 2021

Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980104-4

7 January 2021

Electrical devices for treatment of arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980104-4

7 January 2021

Catheter ablation of ventricular tachycardia with intracardiac shocks: results in 33 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980104-4

7 January 2021

Subendocardial resection for ventricular tachycardia: predictors of surgical success

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980104-4

7 January 2021

Programmed electrical stimulation studies for ventricular tachycardia induction in humans. I. The role of ventricular functional refractoriness in tachycardia induction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980104-4

7 January 2021

Programmed electrical stimulation studies for ventricular tachycardia induction in humans. II. Comparison of indwelling electrode catheter and daily catheter replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980104-4

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980104-4

7 January 2021

Predictors of the success or failure of medical therapy in patients with chronic recurrent sustained ventricular tachycardia: a discriminant analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980104-4

7 January 2021

Mexiletine-quinidine combination: electrophysiologic correlates of a favorable antiarrhythmic interaction in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980104-4

7 January 2021

Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2810%2980104-4

7 January 2021

10.1016/S0735-1097(10)80104-4

Identifiers

DOI

1 reference

10 September 2017

1 reference